1. |
Walton TE, Webb PA, Kramer WL, et al. Epizootic vesicular stomatitis in Colorado, 1982: epidemiologic and entomologic studies. Am J Trop Med Hyg 1987; 36(1): 166-76. doi: 10.4269/ajtmh.1987.36.166.
|
2. |
Walker PJ, Firth C, Widen SG, et al. Evolution of genome size and complexity in the rhabdoviridae. PLoS Pathog 2015; 11(2): e1004664. doi: 10.1371/journal.ppat.1004664.
|
3. |
Liu G, Cao W, Salawudeen A, et al. Vesicular stomatitis virus: from agricultural pathogen to vaccine vector. Pathogens 2021; 10(9): 1902. doi: 10.3390/pathogens10091092.
|
4. |
Clarke DK, Nasar F, Lee M, et al. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations. J Virol 2007; 81(4): 2056-64. doi: 10.1128/jvi.01911-06.
pmid: 17151112
|
5. |
Novella IS. Contributions of vesicular stomatitis virus to the understanding of RNA virus evolution. Curr Opin Microbiol 2003; 6(4): 399-405. doi: 10.1016/s1369-5274(03)00084-5.
pmid: 12941412
|
6. |
Hastie E, Cataldi M, Marriott I, et al. Understanding and altering cell tropism of vesicular stomatitis virus. Virus Res 2013; 176(1-2): 16-32. doi: 10.1016/j.virusres.2013.06.003.
pmid: 23796410
|
7. |
Fletcher P, O’Donnell KL, Doratt BM, et al. Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection. Emerg Microbes Infect 2023; 12(2): 2239950. doi: 10.1080/22221751.2023.2239950.
|
8. |
Marek J, Hanesch L, Krabbe T, et al. Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy. Mol Ther Oncolytics 2023; 30: 117-31. doi: 10.1016/j.omto.2023.08.001.
|
9. |
Matsuda S, Iriyama C, Yokozaki S, et al. Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3. J Hum Genet 2001; 46(8): 483-6. doi: 10.1007/s100380170049.
pmid: 11501947
|
10. |
Delfín DA, DeAguero JL, McKown EN. The extracellular matrix protein ABI3BP in cardiovascular health and disease. Front Cardiovasc Med 2019; 6: 23. doi: 10.3389/fcvm.2019.00023.
|
11. |
Feng Y, Han X, Zhang Z, et al. ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor. Front Genet 2022; 13: 1085785. doi: 10.3389/fgene.2022.1085785.
|
12. |
Latini FR, Hemerly JP, Oler G, et al. Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion. Endocr Relat Cancer 2008; 15(3): 787-99. doi: 10.1677/erc-08-0079.
|
13. |
Li P, Yuan H, Kuang X, et al. Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma. Medicine 2022; 101(47): e31798. doi: 10.1097/md.0000000000031798.
|
14. |
Cai H, Li Y, Qin D, et al. The depletion of ABI3BP by microRNA-183 promotes the development of esophageal carcinoma. Mediat Inflamm 2020; 2020: 3420946. doi: 10.1155/2020/3420946.
|
15. |
Feng Y, Tao F, Qiao H, et al. A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration. Front Oncol 2023; 13: 1159725. doi: 10.3389/fonc.2023.1159725.
|
16. |
Hodgkinson CP, Naidoo V, Patti KG, et al. ABI3BP is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology. Stem Cells 2013; 31(8): 1669-82. doi: 10.1002/stem.1416.
pmid: 23666637
|
17. |
Song N, Qi Q, Cao R, et al. MAVS O-GlcNAcylation is essential for host antiviral immunity against lethal RNA viruses. Cell Rep 2019; 28(9): 2386-96. doi: 10.1016/j.celrep.2019.07.085.
pmid: 31461653
|
18. |
Latini FR, Hemerly JP, Freitas BC, et al. ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence. BMC Cancer 2011; 11: 11. doi: 10.1186/1471-2407-11-11.
pmid: 21223585
|
19. |
Dai Z, Pendergast AM. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev 1995; 9(21): 2569-82. doi: 10.1101/gad.9.21.2569.
|
20. |
Bae J, Sung BH, Cho IH, et al. NESH regulates dendritic spine morphology and synapse formation. PLOS ONE 2012; 7(4): e34677. doi: 10.1371/journal.pone.0034677.
|
21. |
Miyazaki K, Matsuda S, Ichigotani Y, et al. Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein. Biochimica et Biophysica Acta (BBA) 2000; 1493(1-2): 237-41. doi: 10.1016/s0167-4781(00)00158-5.
|
22. |
Hodgkinson CP, Gomez JA, Payne AJ, et al. ABI3BP regulates cardiac progenitor cell proliferation and differentiation. Circ Res 2014; 115(12): 1007-16. doi: 10.1161/circresaha.115.304216.
pmid: 25296984
|
23. |
Manabe R, Tsutsui K, Yamada T, et al. Transcriptome-based systematic identification of extracellular matrix proteins. Proc Natl Acad Sci USA 2008; 105(35): 12849-54. doi: 10.1073/pnas.0803640105.
|
24. |
Roberts KL, Baines JD. Actin in herpesvirus infection. Viruses 2011; 3 (4): 336-46. doi: 10.3390/v3040336.
pmid: 21994736
|
25. |
Nelemans T, Kikkert M. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses 2019; 11(10): 961. doi: 10.3390/v11100961.
|
26. |
Stefan KL, Kim MV, Iwasaki A, et al. Commensal microbiota modulation of natural resistance to virus infection. Cell 2020; 183(5): 1312-24. doi: 0.1016/j.cell.2020.10.047.
pmid: 33212011
|
27. |
Roers A, Hiller B, Hornung V. Recognition of endogenous nucleic acids by the innate immune system. Immunity 2016; 44(4): 739-54. doi: 10.1016/j.immuni.2016.04.002.
pmid: 27096317
|
28. |
Seth RB, Sun L, Ea CK, et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122(5): 669-82. doi: 10.1016/j.cell.2005.08.012.
pmid: 16125763
|
29. |
Binder M, Eberle F, Seitz S, et al. Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J Biol Chem 2011; 286(31): 27278-87. doi: 10.1074/jbc.m111.256974.
pmid: 21659521
|
30. |
Ren Z, Ding T, Zuo Z, et al. Regulation of MAVS expression and signaling function in the antiviral innate immune response. Front Immunol 2020; 11: 1030. doi: 10.3389/fimmu.2020.01030.
pmid: 32536927
|
31. |
Zheng Z, Zhao M, Shan H, et al. Noncanonical autophagy is a new strategy to inhibit HSV-1 through STING1 activation. Autophagy 2023; 19(12): 3096-112. doi: 10.1080/15548627.2023.2237794.
|
32. |
Chakravarty S, Subramanian G, Popli S, et al. Interferon-stimulated gene TDRD 7 interacts with AMPK and inhibits its activation to suppress viral replication and pathogenesis. mBio 2023; 14(5): e0061123. doi: 10.1128/mbio.00611-23.
|